Cargando…
C-reactive protein impairs immune response of CD8(+) T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma
BACKGROUND: C-reactive protein (CRP) is a prototypical acute phase protein in humans with the function of regulating immune cells. Serum CRP levels are elevated in multiple myeloma (MM), associated with MM cell proliferation and bone destruction. However, its direct effects on T lymphocytes in MM ha...
Autores principales: | Jiang, Jinxing, Peng, Ziyi, Wang, Junying, Chen, Mengping, Wan, Yike, Huang, Honghui, Liu, Zhiqiang, Wang, Jingya, Hou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582887/ https://www.ncbi.nlm.nih.gov/pubmed/37844994 http://dx.doi.org/10.1136/jitc-2023-007593 |
Ejemplares similares
-
FcγRIIB mediates antigen-independent inhibition on human B lymphocytes through Btk and p38 MAPK
por: Tzeng, Shiang-Jong, et al.
Publicado: (2015) -
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016) -
The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019) -
Transmembrane domain dependent inhibitory function of FcγRIIB
por: Wang, Junyi, et al.
Publicado: (2018) -
FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021)